DHR · NYSE · Medical - Diagnostics & Research

Danaher

Supplies bioprocessing, life-science, and diagnostic tools with recurring consumables and service.

$215.50
After-hours close−0.55 (−0.25%)
At close$216.05(+0.17%)

Breakdown13F · Form 4

Institutions 109.00%Insiders 0.78%

A 13F quarter can total more than the shares outstanding — sub-advisers file the same block twice, and a filer's own share count can be a quarter stale. No split is drawn from it.

Shares outstanding 702.99M · Float 625.84M · 89.0% free float

Top shareholders13F · 13D/G · Form 4

HolderShares% outstandingFormFiled
BlackRock, Inc.55.08M7.84%13FAug 7, 2026
Vanguard Capital Management LLC41.38M5.89%13FAug 13, 2026
FMR LLC29.54M4.20%13FAug 13, 2026
State Street Corp28.46M4.05%13FAug 7, 2026
Wellington Management Group LLP16.32M2.32%13FAug 14, 2026

Institutions13F, as of Jun 30, 2026

2,174 holders · 766.27M shares · 161 new positions · 840 increased · 1,016 reduced · 226 closed

HolderShares% outstandingChg q/qFiled
BlackRock, Inc.55.08M7.84%+3.44MAug 7, 2026
Vanguard Capital Management LLC41.38M5.89%+249.3KAug 13, 2026
FMR LLC29.54M4.20%+7.01MAug 13, 2026
State Street Corp28.46M4.05%+561.8KAug 7, 2026
Wellington Management Group LLP16.32M2.32%+1.54MAug 14, 2026
Capital International Investors15.50M2.21%+1.49MAug 12, 2026
Geode Capital Management, LLC14.28M2.03%+134.6KAug 12, 2026
Vanguard Portfolio Management LLC14.21M2.02%+250.5KAug 13, 2026

Beneficial owners13D/G · 5% or more, as filed

Holder% of classSharesFormFiled
Vanguard Capital Management6.69%47.38M13GApr 29, 2026

InsidersForm 4

InsiderRoleShares% outstandingFiled
Steven M. Ralesdirector, officer: Chairman3.61M0.51%Aug 6, 2026
Mitchell P. Ralesdirector, officer: Chairman of Exec. Committee1.33M0.19%Aug 6, 2026
Alan G. Spoondirector124.8K0.02%May 19, 2026
Christopher Paul Rileyofficer: Executive Vice President61.5K0.01%Aug 6, 2026
Elias A. Zerhounidirector45.3K0.01%Jul 16, 2026
Rainer Blairdirector, officer: President & CEO38.0K0.01%Aug 24, 2026
Matthew McGrewofficer: Executive Vice President37.0K0.01%Mar 3, 2026
Jose-Carlos Gutierrez-Ramosofficer: SVP, Chief Science Officer32.5K0.00%Aug 6, 2026
Linda Fillerdirector26.8K0.00%Jul 16, 2026
Gregory M. Milosevichofficer: Executive Vice President24.5K0.00%Aug 6, 2026

22 people have not refiled in the last 18 months (4.26M shares), so they are not in the figure above

Latest trades

DateInsiderTypeSharesAvg priceOwned after
Aug 21, 2026
Rainer Blairdirector, officer: President & CEO
Sale · 3 lots58,255$218.630
May 1, 2026
Alan G. Spoondirector
Sale1,358$174.67124,094
Feb 19, 2026
Gregory M. Milosevichofficer: Executive Vice President
Sale1,320$208.015,099
Nov 25, 2025
Mitchell P. Ralesdirector, officer: Chairman of Exec. Committee
Sale · 2 lots40,625$230.38850,000
Nov 18, 2025
Teri Listdirector
Sale3,298$226.5020,762
Nov 12, 2025
Mitchell P. Ralesdirector, officer: Chairman of Exec. Committee
Sale · 4 lots437,000$218.69553,228
Nov 12, 2025
Brian W. Ellisofficer: Senior Vice President - GC
Sale · 2 lots21,776$219.2314,553
Nov 11, 2025
Matthew McGrewofficer: EVP & Chief Financial Officer
Sale16,172$214.6220,062
Nov 10, 2025
Georgeann Coucharaofficer: SVP, Human Resources
Sale · 2 lots5,174$210.422,625
Oct 31, 2025
Mitchell P. Ralesdirector, officer: Chairman of Exec. Committee
Sale · 3 lots600,000$216.06990,228

CongressHouse and Senate disclosures

MemberTypeAmountOwnerTradedDisclosed
Rep. Michael McCaul · TX10Purchase$1,001 – $15,000SpouseJun 16, 2026Jul 13, 2026
Rep. Michael McCaul · TX10Purchase$1,001 – $15,000SpouseJun 5, 2026Jul 13, 2026
Rep. Michael McCaul · TX10Purchase$1,001 – $15,000SpouseJun 3, 2026Jul 13, 2026
Rep. Michael McCaul · TX10Purchase$1,001 – $15,000SpouseJun 2, 2026Jul 13, 2026
Rep. Ro Khanna · CA17Purchase$15,001 – $50,000Jun 2, 2026Jul 8, 2026